Learn More
Selleck Chemical LLC Ixazomib Citrate (MLN9708) S4432-25mg

Supplier: Selleck Chemical LLC S443225MG
Ixazomib Citrate (MLN9708) is a prodrug of Ixazomib (MLN2238) which is a selective orally bioavailable inhibitor of 20S proteasome that inhibits the chymotrypsin-like proteolytic ( 5) site with IC50 of 3 4 nM and Ki of 0 93 nM respectively Ixazomib (MLN2238) also inhibits caspase-like ( 1) and trypsin-like ( 2) proteolytic sites with IC50 of 31 nM and 3500 nM respectively
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.